Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin b2, feverfew, andrographis paniculata and coenzyme q10 for episodic migraine prophylaxis

HIGHLIGHTS

  • who: Michail Vikelis et al. from the Glyfada Headache Clinic, Glyfada, Greece Headache Outpatient Clinic, st Department of Neurology, National and Kapodistrian University of Athens have published the article: Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis, in the Journal: (JOURNAL) of 26/03/2018
  • what: The aim of the study was to evaluate the efficacy of the supplementation, as expressed by the change in mean number of migraine days between baseline period (BSL) and the third month of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?